Open AccessModulation of gut mucosal microbiota as a mechanism of probiotics‐based adjunctive therapy for ulcerative colitis
Author(s) -
Chen Ping,
Xu Haiyan,
Tang Hai,
Zhao Feiyan,
Yang Chengcong,
Kwok LaiYu,
Cong Chunli,
Wu YanFang,
Zhang Wenyi,
Zhou XiaoFeng,
Zhang Heping
Publication year - 2020
Publication title -
microbial biotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.287
H-Index - 74
ISSN - 1751-7915
DOI - 10.1111/1751-7915.13661
Subject(s) - probiotic , lactobacillus casei , ulcerative colitis , gastroenterology , bifidobacterium , faecalibacterium prausnitzii , bifidobacterium animalis , placebo , gut flora , mesalazine , medicine , bifidobacterium bifidum , akkermansia , lactobacillus , bacteroides fragilis , microbiology and biotechnology , biology , immunology , bacteria , antibiotics , disease , pathology , genetics , alternative medicine
Ulcerative colitis is a chronic colon inflammatory disease, the probiotics might alleviate UC symptoms by modulating the gut mucosal microbiota, our research has provided new insights into the mechanism of symptom alleviation in UC by applying probiotics‐based adjunctive treatment.